MEDICINOVA, INC. Deferred Tax Assets, Tax Deferred Expense
MEDICINOVA, INC. (MNOV) had Deferred Tax Assets, Tax Deferred Expense of $934 as of 2022-12-31, per its 10-K filed 2024-02-15.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2024-02-15
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $934.00.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense $30.78K; Deferred Tax Assets, Tax Deferred Expense as first filed $30.78M.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense $98.41M.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense $175.83M.
| Period end | Deferred Tax Assets, Tax Deferred Expense | Deferred Tax Assets, Tax Deferred Expense as first filed |
|---|---|---|
| 2022-12-31 | $934.00 10-K · filed 2024-02-15 | |
| 2021-12-31 | $30.78K 10-K/A · filed 2023-03-28 | $30.78M 10-K · filed 2022-02-16 |
| 2020-12-31 | $98.41M 10-K · filed 2022-02-16 | |
| 2019-12-31 | $175.83M 10-K · filed 2021-02-19 | |
| 2018-12-31 | $176.00K 10-K · filed 2020-02-13 | $286.00K 10-K · filed 2019-02-13 |
| 2017-12-31 | $286.00K 10-K · filed 2020-02-13 | $429.00K 10-K · filed 2018-02-13 |
| 2016-12-31 | $838.00K 10-K · filed 2018-02-13 | |
| 2015-12-31 | $1.08M 10-K · filed 2018-02-13 | |
| 2014-12-31 | $1.33M 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |